Retatrutide 20mg

Includes: bacteriostatic water, alcohol pads, mixing syringe, and insulin syringes – everything needed for complete research preparation.

Retatrutide 20 mg — Research Focus: Metabolism & Endocrinology

Research Background Retatrutide is a novel investigational peptide developed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. It was first described in the early 2020s during preclinical research programs exploring advanced therapeutics for metabolic disorders. Studies in 2020s animal and early clinical research highlighted its potential for effects on glucose metabolism, energy regulation, and weight-related pathways. It remains an experimental compound strictly for laboratory use, studied under the context of endocrinology and metabolic biology.

Research Applications

• Studies of GLP-1, GIP, and glucagon receptor biology
• Metabolic and endocrine pathway research
• In vitro pharmacological profiling
• Investigations into peptide-based metabolic regulation

Grail Formula Quality

All Grail Formula peptides are produced under strict research quality standards. This batch (GF082025026, COA published August 22, 2025) was tested by Liquilabs s.r.o. and confirmed to be > 99.8% pure. The COA also confirmed no detectable heavy metals, no microbial contamination, and endotoxin levels below 0.001 EU/mg. When you choose Grail Formula Retatrutide, you are choosing our brand, our quality.

Analytical Highlights (COA)

• Batch: GF082025026
• COA publication date: August 22, 2025
• Content: 19.90 mg ± 0.1
• Purity: > 99.8%
• Identification: RT 0.99 ± 0.00 / spectrum 995 ± 20
• Endotoxin: < 0.001 EU/mg
• Bioburden: not detected (no bacteria, yeast, or mold)
• Heavy metals (As, Cd, Pb, Hg, Ni, Co, V): not detected
• Tested and reported by Liquilabs s.r.o. — independent laboratory

Research Use Only

This compound is intended strictly for scientific and laboratory research. It is not designed for human consumption, medical use, or cosmetic application. Always handle in accordance with professional laboratory safety standards.

• Name: Retatrutide, 20 mg
• Purity: > 99.8% — verified by independent third-party testing (COA available)
• Research areas: metabolic regulation, endocrinology, in vitro pharmacology
• Accessories included: bacteriostatic water, alcohol pads, mixing syringe, insulin syringes
• Grail Formula by 24PEPTIDES — each batch tested for heavy metals, endotoxins, and microbial safety